Suchergebnisse - "Luo, Xing"

PubPharm (4)

1

Corrigendum to "MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction" [Redox Biol. 69 (2024) 102987

enthalten in: Redox biology | 2024

von Luo, X. | Wang, Y. | Zhu, X. | +13

ErratumFor: Redox Biol. 2023 Dec 7;69:102987. - PMID 38100883

2

MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction

enthalten in: Redox biology | 2024

von Luo, X. | Wang, Y. | Zhu, X. | +13

ErratumIn: Redox Biol. 2024 Feb;69:103009. - PMID 38171959

3

Corrigendum to "A novel anti-atherosclerotic mechanism of quercetin : Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis" [Redox Biol. 57 (2022) 102511

enthalten in: Redox biology | 2022

von Luo, X. | Weng, X. | Bao, X. | +12

ErratumFor: Redox Biol. 2022 Oct 14;57:102511. - PMID 36274522

4

A novel anti-atherosclerotic mechanism of quercetin : Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis

enthalten in: Redox biology | 2022

von Luo, X. | Weng, X. | Bao, X. | +13

ErratumIn: Redox Biol. 2022 Dec;58:102548. - PMID 36435736

1
[1]